|
|
Advances in molecular mechanism of milkvetch root and Chinese angelica to improve myelosuppression after chemotherapy |
DING Huan1 WU Chengjie2 PAN Yalan1 XU Guihua1 YANG Min1 SHI Xuqin3 WANG Qing1▲ |
1.College of Nursing, Nanjing University of Chinese Medicine, Jiangsu Province, Nanjing 210023, China;
2.the First School of Clinical Medicine, Nanjing University of Chinese Medicine, Jiangsu Province, Nanjing 210023, China;
3.College of Pharmacy, Nanjing University of Chinese Medicine, Jiangsu Province, Nanjing 210023, China |
|
|
Abstract Myelosuppression is a common toxic and side effect after chemotherapy, mainly related to injury of hematopoietic stem cells and hemopoietic microenvironment. Milkvetch root and Chinese angelica have the functions of benefiting qi and blood, strengthening and supplementing deficiency, and are often used to improve myelosuppression. Pharmacological studies have found that the effective components of the two drugs can improve the myelosuppression after chemotherapy by promoting the proliferation and differentiation of hemopoietic stem cells. The specific mechanism is related to multiple pathways, but it has not been clarified yet, affecting further clinical application and promotion. This paper summarizes the molecular mechanism of milkvetch root and Chinese angelica to improve the microenvironment of bone marrow, so as to expand the research idea of the molecular mechanism of traditional Chinese medicine benefiting qi and blood to improve myelosuppression, and lays a foundation for the promotion of milkvetch root and Chinese angelica to improve the clinical application of myelosuppression.
|
|
|
|
|
[1] 王宁,刘硕,杨雷,等.2018全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2019,5(1):87-97.
[2] Torre LA,Bray F,Siegel RL,et al. Global cancer statistics,2012 [J]. CA Cancer J Clin,2015,65(2):87-108.
[3] 范奎,代良敏,伍振峰,等.放化疗所致骨髓抑制的研究进展[J].中华中医药杂志,2017,32(1):210-214.
[4] 田兆兴,杨倩.中医药防治肿瘤放化疗后骨髓抑制的应用及研究进展[J].中国医院药学杂志,2017,37(2):190-193.
[5] 丁香,王丽帆,刘志强,等.当归补血汤干预NRF2-Notch信号调控辐射旁效应“毒损髓络”的机制研究[J].时珍国医国药,2018,29(5):1042-1045.
[6] 徐正阳,柴烁,张小晴,等.化疗抑制下骨髓BMP4对造血干/祖细胞周期、凋亡的调控及其机制[J].中国实验血液学杂志,2019,27(4):1265-1271.
[7] 陈凌波,张珂胜,黄小平,等.黄芪当归配伍对骨髓造血功能抑制小鼠造血祖细胞增殖的影响[J].中草药,2016, 47(24):4395-4400.
[8] Mu X,Zhang Y,Li J,et al. Angelica Sinensis Polysaccharide Prevents Hematopoietic Stem Cells Senescence in D-Galactose-Induced Aging Mouse Model [J]. Stem Cells Int,2017,2017:3508907.
[9] Mizuno S,Iino T,Ozawa H,et al. Notch1 expression is regulated at the post-transcriptional level by the 3’ untranslated region in hematopoietic stem cell development [J]. Int J Hematol,2018,107(3):311-319.
[10] Kim AD,Melick CH,Clements WK,et al. Discrete Notch signaling requirements in the specification of hematopoietic stem cells [J]. EMBO J,2014,33(20):2363-2373.
[11] 路玫,杜雪源,滕迎春,等.针灸对环磷酰胺化疗小鼠骨髓造血细胞中Notch信号传导通路相关差异基因Numb1、Numb2的影响[J].中华中医药学刊,2018,36(9):2055-2058.
[12] 陈娟娟,周思朗,夏鸳鸯,等.Notch信号途径对放疗后骨髓谱系造血重建的影响及其机制[J].山东医药,2018, 58(8):26-30.
[13] Luis TC,Naber BA,Roozen PP,et al. Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion [J]. Cell Stem Cell,2011,9(4):345-356.
[14] Zheng P,Chang X,Lu Q,et al. Cytopenia and autoimmune diseases: A vicious cycle fueled by mTOR dysregulation in hematopoietic stem cells [J]. J Autoimmun,2013,41:182-187.
[15] 曾慧红,朱清仙,匡渤海,等.造血干细胞老化与mTOR信号通路[J].中国细胞生物学学报,2017,39(6):811-818.
[16] Naka K,Hirao A. Regulation of Hematopoiesis and Hematological Disease by TGF-β Family Signaling Molecules [J]. Cold Spring Harb Perspect Biol,2017,9(9):a027987.
[17] Blank U,Karlsson S. TGF-β signaling in the control of hematopoietic stem cells [J]. Blood,2015,125(23):3542-3550.
[18] 王洪涛,刘鑫,王梦鸽,等.ERK信号通路在人胚胎干细胞造血分化中的作用研究[J].中国细胞生物学学报,2017,39(6):725-731.
[19] 李昂,邢雅琪,李晓霞,等.氧化应激中ROS对FOXO3a转录因子的调控作用研究进展[J].中国药理学通报,2016, 32(9):1203-1207.
[20] Xu G,Wu H,Zhang J,et al. Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice [J]. Free Radic Biol Med,2015,87:15-25.
[21] Liang R,Ghaffari S. Mitochondria and FOXO3 in stem cell homeostasis,a window into hematopoietic stem cell fate determination [J]. J Bioenerg Biomembr,2017,49(4):343-346.
[22] 张琼.足三里穴位注射黄芪注射液对胃癌化疗患者免疫功能的影响[D].南京:南京中医药大学,2014.
[23] 李明尧,朱土福,张春宁.注射用黄芪多糖对宫颈癌化疗患者骨髓抑制的效果分析[J].广州医药,2016,47(5):36-38.
[24] 毛丹,黄立中,周春花,等.穴位注射黄芪注射液防治化疗毒副反应的疗效观察[J].中国中医急症,2014,23(6):1133-1135.
[25] 傅金龙,汪勇,胡可,等.黄芪对腹腔镜下胃大部切除术后胃癌患者T细胞亚群的影响[J].中华中医药学刊,2017,35(10):2654-2656.
[26] 刘素霞.黄芪多糖对非小细胞肺癌患者髓源性抑制细胞的影响[D].杭州:浙江大学,2018.
[27] 李秀,初杰,李影迪,等.当归/黄芪多糖对腹腔注射环磷酰胺小鼠骨髓造血影响随机平行对照研究[J].实用中医内科杂志,2017,31(5):52-58.
[28] 崔运浩.黄芪甲苷、毛蕊异黄酮调控化疗性骨髓抑制小鼠骨髓干细胞机制研究[D].沈阳:辽宁中医药大学,2016.
[29] 崔运浩,初杰,范颖,等.黄芪甲苷、毛蕊异黄酮及其配伍对化疗性骨髓抑制小鼠骨髓干细胞JAK2/STAT5信号转导通路的影响[J].中华中医药学刊,2016,34(7):1576-1580.
[30] 王书韵.养血健脾浓煎剂防治TP方案化疗所致骨髓抑制的临床研究[D].南京:南京中医药大学,2019.
[31] 肖遥.加味当归补血汤治疗结直肠癌化疗后骨髓抑制及免疫功能下降的临床研究[D].南京:南京中医药大学,2018.
[32] 熊丽溶.当归多糖对5-氟尿嘧啶损伤骨髓基质细胞的保护作用[D].重庆:重庆医科大学,2017.
[33] 张雁.当归多糖促进急性放射损伤小鼠造血功能恢复及机制研究[D].重庆:重庆医科大学,2010.
[34] 徐昊,黄小平,张伟,等.黄芪和当归的主要活性成分配伍对骨髓抑制小鼠造血功能的影响[J].中国药理学通报,2019,35(5):707-713.
[35] Ma ZC,Hong Q,Wang YG,et al. Effects of ferulic acid on hematopoietic cell recovery in whole-body gamma irradiated mice [J]. Int J Radiat Biol,2011,87(5):499-505.
[36] 杨容华,王芳.黄芪注射液穴位注射防治卵巢癌化疗后骨髓抑制的临床疗效观察[J].针灸临床杂志,2015,31(3):50-53.
[37] 武震凤.基于数据挖掘的骨髓抑制组方用药规律研究[D].广州:广州中医药大学,2018.
[38] 姚静,施钧瀚,桂新景,等.基于HPLC指纹图谱评价的当归补血汤传统汤剂与配方颗粒汤剂的成分差异分析[J].中草药,2019,50(11):2567-2574. |
|
|
|